Table of Content

1 Oxaliplatin Injection Market Overview
1.1 Product Overview and Scope of Oxaliplatin Injection
1.2 Oxaliplatin Injection Segment by Type
1.2.1 Global Oxaliplatin Injection Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Other
1.3 Oxaliplatin Injection Segment by Application
1.3.1 Oxaliplatin Injection Sales Comparison by Application: (2021-2027)
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Other
1.4 Global Oxaliplatin Injection Market Size Estimates and Forecasts
1.4.1 Global Oxaliplatin Injection Revenue 2016-2027
1.4.2 Global Oxaliplatin Injection Sales 2016-2027
1.4.3 Oxaliplatin Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Oxaliplatin Injection Market Competition by Manufacturers
2.1 Global Oxaliplatin Injection Sales Market Share by Manufacturers (2016-2021)
2.2 Global Oxaliplatin Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oxaliplatin Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oxaliplatin Injection Manufacturing Sites, Area Served, Product Type
2.5 Oxaliplatin Injection Market Competitive Situation and Trends
2.5.1 Oxaliplatin Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oxaliplatin Injection Players Market Share by Revenue
2.5.3 Global Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oxaliplatin Injection Retrospective Market Scenario by Region
3.1 Global Oxaliplatin Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Oxaliplatin Injection Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Oxaliplatin Injection Market Facts & Figures by Country
3.3.1 North America Oxaliplatin Injection Sales by Country
3.3.2 North America Oxaliplatin Injection Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oxaliplatin Injection Market Facts & Figures by Country
3.4.1 Europe Oxaliplatin Injection Sales by Country
3.4.2 Europe Oxaliplatin Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oxaliplatin Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Oxaliplatin Injection Sales by Region
3.5.2 Asia Pacific Oxaliplatin Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oxaliplatin Injection Market Facts & Figures by Country
3.6.1 Latin America Oxaliplatin Injection Sales by Country
3.6.2 Latin America Oxaliplatin Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oxaliplatin Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Oxaliplatin Injection Sales by Country
3.7.2 Middle East and Africa Oxaliplatin Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oxaliplatin Injection Historic Market Analysis by Type
4.1 Global Oxaliplatin Injection Sales Market Share by Type (2016-2021)
4.2 Global Oxaliplatin Injection Revenue Market Share by Type (2016-2021)
4.3 Global Oxaliplatin Injection Price by Type (2016-2021)

5 Global Oxaliplatin Injection Historic Market Analysis by Application
5.1 Global Oxaliplatin Injection Sales Market Share by Application (2016-2021)
5.2 Global Oxaliplatin Injection Revenue Market Share by Application (2016-2021)
5.3 Global Oxaliplatin Injection Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi-Aventis Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Yakult honsha
6.2.1 Yakult honsha Corporation Information
6.2.2 Yakult honsha Description and Business Overview
6.2.3 Yakult honsha Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Yakult honsha Product Portfolio
6.2.5 Yakult honsha Recent Developments/Updates
6.3 Dr Reddy's laboratories
6.3.1 Dr Reddy's laboratories Corporation Information
6.3.2 Dr Reddy's laboratories Description and Business Overview
6.3.3 Dr Reddy's laboratories Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Dr Reddy's laboratories Product Portfolio
6.3.5 Dr Reddy's laboratories Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Corporation Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sun Pharmaceutical Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Fresenius Kabi Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Hospira(Pfizer)
6.6.1 Hospira(Pfizer) Corporation Information
6.6.2 Hospira(Pfizer) Description and Business Overview
6.6.3 Hospira(Pfizer) Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hospira(Pfizer) Product Portfolio
6.7.5 Hospira(Pfizer) Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Mylan Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Jiangsu Hengrui Medicine
6.9.1 Jiangsu Hengrui Medicine Corporation Information
6.9.2 Jiangsu Hengrui Medicine Description and Business Overview
6.9.3 Jiangsu Hengrui Medicine Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Jiangsu Hengrui Medicine Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.10 Nanjing Pharmaceutical Factory
6.10.1 Nanjing Pharmaceutical Factory Corporation Information
6.10.2 Nanjing Pharmaceutical Factory Description and Business Overview
6.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Nanjing Pharmaceutical Factory Product Portfolio
6.10.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
6.11 Jiangsu Aosaikang Pharmaceutical
6.11.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.11.2 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Description and Business Overview
6.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Jiangsu Aosaikang Pharmaceutical Product Portfolio
6.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.12 Qilu Pharmaceutical
6.12.1 Qilu Pharmaceutical Corporation Information
6.12.2 Qilu Pharmaceutical Oxaliplatin Injection Description and Business Overview
6.12.3 Qilu Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Qilu Pharmaceutical Product Portfolio
6.12.5 Qilu Pharmaceutical Recent Developments/Updates
6.13 Hisun Pharmaceutical
6.13.1 Hisun Pharmaceutical Corporation Information
6.13.2 Hisun Pharmaceutical Oxaliplatin Injection Description and Business Overview
6.13.3 Hisun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Hisun Pharmaceutical Product Portfolio
6.13.5 Hisun Pharmaceutical Recent Developments/Updates
6.14 Lunan Pharmaceutical
6.14.1 Lunan Pharmaceutical Corporation Information
6.14.2 Lunan Pharmaceutical Oxaliplatin Injection Description and Business Overview
6.14.3 Lunan Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Lunan Pharmaceutical Product Portfolio
6.14.5 Lunan Pharmaceutical Recent Developments/Updates
6.15 Luoxin
6.15.1 Luoxin Corporation Information
6.15.2 Luoxin Oxaliplatin Injection Description and Business Overview
6.15.3 Luoxin Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Luoxin Product Portfolio
6.15.5 Luoxin Recent Developments/Updates
6.16 Halfsky Pharmacy
6.16.1 Halfsky Pharmacy Corporation Information
6.16.2 Halfsky Pharmacy Oxaliplatin Injection Description and Business Overview
6.16.3 Halfsky Pharmacy Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Halfsky Pharmacy Product Portfolio
6.16.5 Halfsky Pharmacy Recent Developments/Updates
6.17 YRPG
6.17.1 YRPG Corporation Information
6.17.2 YRPG Oxaliplatin Injection Description and Business Overview
6.17.3 YRPG Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.17.4 YRPG Product Portfolio
6.17.5 YRPG Recent Developments/Updates
6.18 Hainan Jinrui Pharmaceutical
6.18.1 Hainan Jinrui Pharmaceutical Corporation Information
6.18.2 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Description and Business Overview
6.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Hainan Jinrui Pharmaceutical Product Portfolio
6.18.5 Hainan Jinrui Pharmaceutical Recent Developments/Updates
6.19 Jari Pharmaceutical
6.19.1 Jari Pharmaceutical Corporation Information
6.19.2 Jari Pharmaceutical Oxaliplatin Injection Description and Business Overview
6.19.3 Jari Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Jari Pharmaceutical Product Portfolio
6.19.5 Jari Pharmaceutical Recent Developments/Updates
6.20 Chiatai Tianqing
6.20.1 Chiatai Tianqing Corporation Information
6.20.2 Chiatai Tianqing Oxaliplatin Injection Description and Business Overview
6.20.3 Chiatai Tianqing Oxaliplatin Injection Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Chiatai Tianqing Product Portfolio
6.20.5 Chiatai Tianqing Recent Developments/Updates

7 Oxaliplatin Injection Manufacturing Cost Analysis
7.1 Oxaliplatin Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oxaliplatin Injection
7.4 Oxaliplatin Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oxaliplatin Injection Distributors List
8.3 Oxaliplatin Injection Customers

9 Oxaliplatin Injection Market Dynamics
9.1 Oxaliplatin Injection Industry Trends
9.2 Oxaliplatin Injection Growth Drivers
9.3 Oxaliplatin Injection Market Challenges
9.4 Oxaliplatin Injection Market Restraints

10 Global Market Forecast
10.1 Oxaliplatin Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oxaliplatin Injection by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Oxaliplatin Injection by Type (2022-2027)
10.2 Oxaliplatin Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oxaliplatin Injection by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Oxaliplatin Injection by Application (2022-2027)
10.3 Oxaliplatin Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oxaliplatin Injection by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Oxaliplatin Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oxaliplatin Injection Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Oxaliplatin Injection Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Oxaliplatin Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Oxaliplatin Injection Covered in This Study
Table 5. Global Oxaliplatin Injection Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Oxaliplatin Injection Sales Share by Manufacturers (2016-2021)
Table 7. Global Oxaliplatin Injection Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Oxaliplatin Injection Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Oxaliplatin Injection Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Oxaliplatin Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Oxaliplatin Injection Product Type
Table 12. Global Oxaliplatin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oxaliplatin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin Injection as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oxaliplatin Injection Sales by Region (2016-2021) & (K Units)
Table 16. Global Oxaliplatin Injection Sales Market Share by Region (2016-2021)
Table 17. Global Oxaliplatin Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Oxaliplatin Injection Sales by Country (2016-2021) & (K Units)
Table 19. North America Oxaliplatin Injection Sales Market Share by Country (2016-2021)
Table 20. North America Oxaliplatin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Oxaliplatin Injection Revenue Market Share by Country (2016-2021)
Table 22. Europe Oxaliplatin Injection Sales by Country (2016-2021) & (K Units)
Table 23. Europe Oxaliplatin Injection Sales Market Share by Country (2016-2021)
Table 24. Europe Oxaliplatin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Oxaliplatin Injection Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Oxaliplatin Injection Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Oxaliplatin Injection Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Oxaliplatin Injection Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Oxaliplatin Injection Revenue Market Share by Region (2016-2021)
Table 30. Latin America Oxaliplatin Injection Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Oxaliplatin Injection Sales Market Share by Country (2016-2021)
Table 32. Latin America Oxaliplatin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Oxaliplatin Injection Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Oxaliplatin Injection Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Oxaliplatin Injection Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Oxaliplatin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Oxaliplatin Injection Revenue Market Share by Country (2016-2021)
Table 38. Global Oxaliplatin Injection Sales (K Units) by Type (2016-2021)
Table 39. Global Oxaliplatin Injection Sales Market Share by Type (2016-2021)
Table 40. Global Oxaliplatin Injection Revenue (Million US$) by Type (2016-2021)
Table 41. Global Oxaliplatin Injection Revenue Share by Type (2016-2021)
Table 42. Global Oxaliplatin Injection Price (US$/Unit) by Type (2016-2021)
Table 43. Global Oxaliplatin Injection Sales (K Units) by Application (2016-2021)
Table 44. Global Oxaliplatin Injection Sales Market Share by Application (2016-2021)
Table 45. Global Oxaliplatin Injection Revenue (Million US$) by Application (2016-2021)
Table 46. Global Oxaliplatin Injection Revenue Share by Application (2016-2021)
Table 47. Global Oxaliplatin Injection Price (US$/Unit) by Application (2016-2021)
Table 48. Sanofi-Aventis Corporation Information
Table 49. Sanofi-Aventis Description and Business Overview
Table 50. Sanofi-Aventis Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi-Aventis Oxaliplatin Injection Product
Table 52. Sanofi-Aventis Recent Developments/Updates
Table 53. Yakult honsha Corporation Information
Table 54. Yakult honsha Description and Business Overview
Table 55. Yakult honsha Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Yakult honsha Oxaliplatin Injection Product
Table 57. Yakult honsha Recent Developments/Updates
Table 58. Dr Reddy's laboratories Corporation Information
Table 59. Dr Reddy's laboratories Description and Business Overview
Table 60. Dr Reddy's laboratories Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Dr Reddy's laboratories Oxaliplatin Injection Product
Table 62. Dr Reddy's laboratories Recent Developments/Updates
Table 63. Sun Pharmaceutical Corporation Information
Table 64. Sun Pharmaceutical Description and Business Overview
Table 65. Sun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sun Pharmaceutical Oxaliplatin Injection Product
Table 67. Sun Pharmaceutical Recent Developments/Updates
Table 68. Teva Corporation Information
Table 69. Teva Description and Business Overview
Table 70. Teva Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Teva Oxaliplatin Injection Product
Table 72. Teva Recent Developments/Updates
Table 73. Fresenius Kabi Corporation Information
Table 74. Fresenius Kabi Description and Business Overview
Table 75. Fresenius Kabi Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Fresenius Kabi Oxaliplatin Injection Product
Table 77. Fresenius Kabi Recent Developments/Updates
Table 78. Hospira(Pfizer) Corporation Information
Table 79. Hospira(Pfizer) Description and Business Overview
Table 80. Hospira(Pfizer) Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Hospira(Pfizer) Oxaliplatin Injection Product
Table 82. Hospira(Pfizer) Recent Developments/Updates
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Mylan Oxaliplatin Injection Product
Table 87. Mylan Recent Developments/Updates
Table 88. Jiangsu Hengrui Medicine Corporation Information
Table 89. Jiangsu Hengrui Medicine Description and Business Overview
Table 90. Jiangsu Hengrui Medicine Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Jiangsu Hengrui Medicine Oxaliplatin Injection Product
Table 92. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 93. Nanjing Pharmaceutical Factory Corporation Information
Table 94. Nanjing Pharmaceutical Factory Description and Business Overview
Table 95. Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Nanjing Pharmaceutical Factory Oxaliplatin Injection Product
Table 97. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 98. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 99. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 100. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Product
Table 102. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 103. Qilu Pharmaceutical Corporation Information
Table 104. Qilu Pharmaceutical Description and Business Overview
Table 105. Qilu Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Qilu Pharmaceutical Oxaliplatin Injection Product
Table 107. Qilu Pharmaceutical Recent Developments/Updates
Table 108. Hisun Pharmaceutical Corporation Information
Table 109. Hisun Pharmaceutical Description and Business Overview
Table 110. Hisun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Hisun Pharmaceutical Oxaliplatin Injection Product
Table 112. Hisun Pharmaceutical Recent Developments/Updates
Table 113. Lunan Pharmaceutical Corporation Information
Table 114. Lunan Pharmaceutical Description and Business Overview
Table 115. Lunan Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Lunan Pharmaceutical Oxaliplatin Injection Product
Table 117. Lunan Pharmaceutical Recent Developments/Updates
Table 118. Luoxin Corporation Information
Table 119. Luoxin Description and Business Overview
Table 120. Luoxin Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Luoxin Oxaliplatin Injection Product
Table 122. Luoxin Recent Developments/Updates
Table 123. Halfsky Pharmacy Corporation Information
Table 124. Halfsky Pharmacy Description and Business Overview
Table 125. Halfsky Pharmacy Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Halfsky Pharmacy Oxaliplatin Injection Product
Table 127. Halfsky Pharmacy Recent Developments/Updates
Table 128. YRPG Corporation Information
Table 129. YRPG Description and Business Overview
Table 130. YRPG Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. YRPG Oxaliplatin Injection Product
Table 132. YRPG Recent Developments/Updates
Table 133. Hainan Jinrui Pharmaceutical Corporation Information
Table 134. Hainan Jinrui Pharmaceutical Description and Business Overview
Table 135. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Product
Table 137. Hainan Jinrui Pharmaceutical Recent Developments/Updates
Table 138. Jari Pharmaceutical Corporation Information
Table 139. Jari Pharmaceutical Description and Business Overview
Table 140. Jari Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Jari Pharmaceutical Oxaliplatin Injection Product
Table 142. Jari Pharmaceutical Recent Developments/Updates
Table 143. Chiatai Tianqing Corporation Information
Table 144. Chiatai Tianqing Description and Business Overview
Table 145. Chiatai Tianqing Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Chiatai Tianqing Oxaliplatin Injection Product
Table 147. Chiatai Tianqing Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Oxaliplatin Injection Distributors List
Table 151. Oxaliplatin Injection Customers List
Table 152. Oxaliplatin Injection Market Trends
Table 153. Oxaliplatin Injection Growth Drivers
Table 154. Oxaliplatin Injection Market Restraints
Table 155. Global Oxaliplatin Injection Sales Forecast by Type (2022-2027) & (K Units)
Table 156. Global Oxaliplatin Injection Sales Market Share Forecast by Type (2022-2027)
Table 157. Global Oxaliplatin Injection Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 158. Global Oxaliplatin Injection Revenue Market Share Forecast by Type (2022-2027)
Table 159. Global Oxaliplatin Injection Sales Forecast by Application (2022-2027) & (K Units)
Table 160. Global Oxaliplatin Injection Sales Market Share Forecast by Application (2022-2027)
Table 161. Global Oxaliplatin Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 162. Global Oxaliplatin Injection Revenue Market Share Forecast by Application (2022-2027)
Table 163. Global Oxaliplatin Injection Sales Forecast by Region (2022-2027) & (K Units)
Table 164. Global Oxaliplatin Injection Sales Market Share Forecast by Region (2022-2027)
Table 165. Global Oxaliplatin Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 166. Global Oxaliplatin Injection Revenue Market Share Forecast by Region (2022-2027)
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oxaliplatin Injection
Figure 2. Global Oxaliplatin Injection Market Share by Type in 2020 & 2027
Figure 3. Mannitol Product Picture
Figure 4. Glucose Solution Product Picture
Figure 5. Lactose Solution Product Picture
Figure 6. Other Product Picture
Figure 7. Global Oxaliplatin Injection Market Share by Application in 2020 & 2027
Figure 8. Colorectal Cancer
Figure 9. Stomach Cancer
Figure 10. Ovarian Cancer
Figure 11. Other
Figure 12. Global Oxaliplatin Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oxaliplatin Injection Market Size 2016-2027 (US$ Million)
Figure 14. Global Oxaliplatin Injection Sales 2016-2027 (K Units)
Figure 15. Global Oxaliplatin Injection Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Oxaliplatin Injection Sales Share by Manufacturers in 2020
Figure 17. Global Oxaliplatin Injection Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Oxaliplatin Injection Players: Market Share by Revenue in 2020
Figure 19. Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Oxaliplatin Injection Sales Market Share by Region (2016-2021)
Figure 21. Global Oxaliplatin Injection Sales Market Share by Region in 2020
Figure 22. Global Oxaliplatin Injection Revenue Market Share by Region (2016-2021)
Figure 23. Global Oxaliplatin Injection Revenue Market Share by Region in 2020
Figure 24. U.S. Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Oxaliplatin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Oxaliplatin Injection by Type (2016-2021)
Figure 49. Sales Market Share of Oxaliplatin Injection by Application (2016-2021)
Figure 50. Sales Market Share of Oxaliplatin Injection by Application in 2020
Figure 51. Revenue Share of Oxaliplatin Injection by Application (2016-2021)
Figure 52. Revenue Share of Oxaliplatin Injection by Application in 2020
Figure 53. Manufacturing Cost Structure of Oxaliplatin Injection
Figure 54. Manufacturing Process Analysis of Oxaliplatin Injection
Figure 55. Oxaliplatin Injection Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed